week mda announced awarding research grants particular interest living kennedy disease sbma following grant testing potential therapy spinal bulbarmuscular atrophy sbma scientists university michigan medical school ann arbor completing preclinical studies mouse model establish safety efficacy new type therapy silence activity gene mutated sbma abstract research noted announcement noted dr lieberman serves kennedy disease association scientific review board rescue metabolicalterations arq skeletal muscle peripheral androgen receptor genesilencing giorgetti yu z chua jp shimamura r zhao l zhu f venneti pennuto guan hung lieberman ap abstract spinal bulbar muscular atrophy sbma progressive degenerative disorder caused cag glutamine expansion androgen receptor polyq recent studies demonstrate skeletal muscle important site toxicity contributes sbma phenotype sought identify critical pathways altered muscle underlie disease manifestations arq mice led unanticipated identification gene expression changes affecting regulators carbohydrate metabolism similar triggered denervation arq muscle exhibits diminished glycolysis altered mitochondria impaired response exercise strikingly expression genes regulating muscle energy metabolism rescued following peripheral polyq gene silencing antisense oligonucleotides aso therapeutic strategy alleviates disease data establish occurrence metabolic imbalance sbma muscle triggered peripheral expression polyq indicate alterations energy utilization contribute non neuronal disease manifestations